IRIDEX (IRIX) Set to Announce Earnings on Tuesday

IRIDEX (NASDAQ:IRIX) is set to release its earnings data after the market closes on Tuesday, November 12th.

IRIDEX (NASDAQ:IRIX) last posted its quarterly earnings results on Thursday, August 8th. The medical equipment provider reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.04). IRIDEX had a negative return on equity of 134.37% and a negative net margin of 21.84%. The business had revenue of $12.63 million during the quarter, compared to analysts’ expectations of $12.80 million. During the same period in the prior year, the firm posted ($0.17) earnings per share.

IRIDEX Stock Up 0.7 %

NASDAQ IRIX traded up $0.01 during trading hours on Tuesday, reaching $1.43. The company’s stock had a trading volume of 32,598 shares, compared to its average volume of 29,951. The company has a market capitalization of $23.61 million, a price-to-earnings ratio of -2.15 and a beta of 0.80. IRIDEX has a 1 year low of $1.33 and a 1 year high of $3.65. The firm’s 50-day moving average price is $1.76 and its 200-day moving average price is $2.10.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on IRIDEX in a report on Friday. They set a “hold” rating on the stock.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.